ArticleMikrochimica acta2026
One-pot fabrication and characterization of ZnO nanoflowers using Zanthoxylum simulans and evaluating their biomedical claims.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Novel zinc oxide nanoflowers (ZnO NFs) were synthesized using the aqueous extract of Zanthoxylum simulans. The green synthesized Zs-ZnO NFs were characterized using FT-IR, XPS, XRD, HR-TEM, EDAX, DLS, and zeta potential (ZP) analysis to confirm the physicochemical properties. HR-TEM analysis exposed the flower-like morphology with uniform size. The XPS analysis exposed the elements present in the Zs-ZnO NFs. Further, the Zn element exhibited two binding energy peaks at 1021.41 and 1044.50 eV. The purity of Zs-ZnO NFs was confirmed using EDAX analysis. The Zs-ZnO NFs displayed bactericidal properties against the tested pathogens. To evaluate the effectiveness of Zs-ZnO NFs against dental pathogens via MIC, antibacterial, biofilm ring formation, and TTC assays were performed. A concentration-dependent biofilm inhibition was also observed against Staphylococcus aureus and Streptococcus mutans upon treatment with Zs-ZnO NFs, and it was confirmed using a 2.5D fluorescence imaging technique. A 100 µg/mL of Zs-ZnO NFs treatment displayed bacterial cell death, which was confirmed via dual staining. Furthermore, Zs-ZnO NFs induced protein leakage was observed upon treatment with 100 µg/mL concentration against the pathogens. Cytotoxicity of Zs-ZnO NFs was confirmed using HUVECs cells. Overall, the synthesized Zs-ZnO NFs exhibits efficient bactericidal, antibiofilm and biocompatible properties.
Indexed as
Identifiers
42246990What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.